Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Plos One
|
February 10, 2022
A method for estimating the impact of new vaccine technologies on vaccination coverage rates
Ben Davis, Michael Krautmann, Pascale R Leroueil
Plos One
|
April 5, 2023
A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers
Michael Krautmann, Ben Davis, Pascale R Leroueil
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
February 19, 2010
Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals
Daniel Q McNerny, Pascale R Leroueil, James R Baker
ACS Nano
|
May 10, 2014
Evaluating binding avidities of populations of heterogeneous multivalent ligand-functionalized nanoparticles
Ming-Hsin Li, Seok Ki Choi, Pascale R Leroueil, et al.
Global Health, Science and Practice
|
December 28, 2020
A Rapid Cost Modeling Tool for Evaluating and Improving Public Health Supply Chain Designs
Michael Krautmann, Mariam Zameer, Dorothy Thomas, et al.
Bioconjugate Chemistry
|
April 12, 2017
Ligand Characteristics Important to Avidity Interactions of Multivalent Nanoparticles
Ming-Hsin Li, Hong Zong, Pascale R Leroueil, et al.
The Journal of Physical Chemistry. B
|
July 16, 2008
Poly(amidoamine) dendrimers on lipid bilayers II: Effects of bilayer phase and dendrimer termination
Christopher V Kelly, Pascale R Leroueil, Bradford G Orr, et al.
Accounts of Chemical Research
|
May 4, 2007
Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?
Pascale R Leroueil, Seungpyo Hong, Almut Mecke, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2013
Fluorogenic 'click-on' dendrimer reporter for rapid profiling of cell proliferation
Sascha N Goonewardena, Pascale R Leroueil, Colleen Gemborys, et al.
Bioconjugate Chemistry
|
February 5, 2010
Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach
Yuehua Zhang, Thommey P Thomas, Ankur Desai, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Plos One
|
February 10, 2022
A method for estimating the impact of new vaccine technologies on vaccination coverage rates
Ben Davis, Michael Krautmann, Pascale R Leroueil
Plos One
|
April 5, 2023
A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers
Michael Krautmann, Ben Davis, Pascale R Leroueil
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
February 19, 2010
Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals
Daniel Q McNerny, Pascale R Leroueil, James R Baker
ACS Nano
|
May 10, 2014
Evaluating binding avidities of populations of heterogeneous multivalent ligand-functionalized nanoparticles
Ming-Hsin Li, Seok Ki Choi, Pascale R Leroueil, et al.
Global Health, Science and Practice
|
December 28, 2020
A Rapid Cost Modeling Tool for Evaluating and Improving Public Health Supply Chain Designs
Michael Krautmann, Mariam Zameer, Dorothy Thomas, et al.
Bioconjugate Chemistry
|
April 12, 2017
Ligand Characteristics Important to Avidity Interactions of Multivalent Nanoparticles
Ming-Hsin Li, Hong Zong, Pascale R Leroueil, et al.
The Journal of Physical Chemistry. B
|
July 16, 2008
Poly(amidoamine) dendrimers on lipid bilayers II: Effects of bilayer phase and dendrimer termination
Christopher V Kelly, Pascale R Leroueil, Bradford G Orr, et al.
Accounts of Chemical Research
|
May 4, 2007
Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?
Pascale R Leroueil, Seungpyo Hong, Almut Mecke, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2013
Fluorogenic 'click-on' dendrimer reporter for rapid profiling of cell proliferation
Sascha N Goonewardena, Pascale R Leroueil, Colleen Gemborys, et al.
Bioconjugate Chemistry
|
February 5, 2010
Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach
Yuehua Zhang, Thommey P Thomas, Ankur Desai, et al.
Page
of 3